Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-centre Study to Assess the Efficacy, Safety and Tolerability of Lu AF82422 in Patients With Multiple System Atrophy

NCT05104476 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT05104476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05104476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-centre Study to Assess the Efficacy, Safety and Tolerability of Lu AF82422 in Patients With Multiple System Atrophy
Lead sponsor
H. Lundbeck A/S
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 16, 2021
Completion date
March 7, 2028
Enrollment
64 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy